Commentary: Vaccine Ad Blitz Sidestepped Transparency Rules

COVID Shot

“A bun in the toaster oven,” a woman exclaims off-camera, handing an ultrasound image to family members who erupt into tearful emotion over the news. “Oh my God!” 

The touching baby announcement video then gets down to business as text appears on the screen amidst the ongoing celebration, suggesting the best way to stay alive for this joyous birth is by becoming vaccinated against COVID-19. “Why will you get vaccinated? …  Because some people you just want to meet in person.” 

Read More

Pro-Vaccine Doctors Skeptical of New COVID-19 Boosters: ‘I’d Really Like to See the Data’

Vaccine

The Centers for Disease Control and Prevention is pushing new COVID-19 boosters, claiming that people who don’t stay “up to date” with shots – regardless of how many they’ve already taken – “are more likely to get very sick” while those who take them annually are “much less likely to get very ill, be hospitalized, or even die” from COVID.

The Democratic nominee for president is so committed to staying up to date on jabs that Vice President Kamala Harris made COVID boosting a requirement to work on her campaign, “unless otherwise prohibited by applicable law.” They can also ask the human resources department for a “reasonable accommodation … prior to reporting to an office location.”

Read More

Commentary: The Grueling and Expensive Journey to Treat Vaccine Injury

Moderna Vaccine

$40,000.

That’s how much Kate Zerby has spent trying to put herself back together after the Moderna COVID vaccine wreaked havoc on her body.

As Intellectual Takeout reported back in 2022, Kate Zerby of St. Paul, Minnesota, suffered a serious adverse reaction to her Moderna shot, beginning the night after she got it, February 16, 2021. At 3:30 a.m., she awoke, gripped by a pervading sense of gloom and foreboding and the unsettling sensation that something strange was slithering through her system. At the same time, an interior voice seemed to tell her, “If you get the vaccine again, you will die.”

Read More

FDA Blesses Departing COVID Vaccine Reviewers to Influence Agency ‘Behind the Scenes’ at Moderna

Moderna Vaccine

David Morens, a senior adviser to then-National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci, once told an ally “our FOIA lady” showed him “how to make emails disappear after I am FOIA’d but before the search starts.” He’s now on administrative leave.

Fauci’s former chief of staff, Greg Folkers, appeared to intentionally misspell proper nouns and names likely to be sought in Freedom of Information Act requests related to COVID-19 origins.

Read More

Feds Bet on Wrong COVID Horse Again as Pfizer’s Own Research Casts Doubt on Pricey Paxlovid

Pfizer Research and Development lab La Jolla, CA

There may be a reason Pfizer chose that curious tagline in the drugmaker’s once-inescapable commercials for its COVID-19 oral antiviral – the subject of a “Saturday Night Live” parody – which cost U.S. taxpayers at least $12 billion before the feds tightened the spigot last fall and Pfizer jacked the price to $1,390 for a five-day course.

The nirmatrelvir-ritonavir combination marketed as Paxlovid does no better against so-called long COVID than a placebo taken with ritonavir, according to a new “original investigation” quietly released Friday in JAMA Internal Medicine, published by the Journal of the American Medical Association.

Read More

Genomics Expert Who Discovered DNA Contamination in mRNA Shots Accuses Regulators of Lying About Cancer Risks

Moderna COVID Vaccine

The scientist who first blew the whistle on the DNA contamination in the COVID mRNA injections last year, said Monday that regulators and fact checkers have been “continually wrong” about his alarming discovery, downplaying its significance and telling flat out lies about the potential dangers.

Last April, microbiologist Kevin McKernan, published a paper establishing that simian virus 40 (SV40), a virus found in monkeys and humans, is present in Pfizer and Moderna’s mRNA COVID-19 injections. The discovery was highly significant because SV40 has been linked to cancer in humans, and since the rollout of the mRNA products, the western world has seen a dramatic increase in cancers, especially in previously healthy working aged people.

Read More

COVID Vaccine ‘Adverse Events of Special Interest’ More Common than Expected: CDC-Funded Study

COVID Vaccine

Rep. Debbie Dingell developed a severe nerve condition from a mandatory swine flu vaccine, which initially made her “scared to death” to get a COVID-19 vaccine, she told a congressional hearing last week. 

The Michigan Democrat might want to reconsider her now-unquestioning enthusiasm for COVID vaccines, including those made through traditional methods, in light of a massive international study of “adverse events of special interest” funded by the Centers for Disease Control and Prevention and set to be published in the peer-reviewed Elsevier journal Vaccine.

Read More

Commentary: Moderna Came Up with a Vaccine Against Vaccine Dissent

Moderna Vaccine

Finances at the vaccine manufacturer Moderna began to fall almost as quickly as they had risen, as most Americans resisted getting yet another COVID booster shot. The pharmaceutical company, whose pioneering mRNA vaccine had turned it from small startup to biotech giant worth more than $100 billion in just a few years, reported a third-quarter loss last year of $3.6 billion, as most Americans refused to get another COVID booster shot.

In a September call aimed at shoring up investors, Moderna’s then-chief commercial officer, Arpa Garay, attributed some of the hesitancy pummeling Moderna’s numbers to uninformed vaccine skeptics. “Despite some misinformation,” Garay said, COVID-19 still drove significant hospitalizations. “It really is a vaccine that’s relevant across all age groups,” she insisted.

Read More

Texas AG Ken Paxton Sues Pfizer for Misrepresenting Efficacy of the COVID-19 Jabs and Conspiring to Censor Public Discourse

AG Ken Paxton

Texas Attorney General Ken Paxton announced Thursday that he is suing Pfizer for “unlawfully misrepresenting” Covid-19 vaccine efficacy and conspiring to censor public discourse.

“Pfizer engaged in false, deceptive, and misleading acts and practices by making unsupported claims regarding the company’s COVID-19 vaccine in violation of the Texas Deceptive Trade Practices Act,” Paxton said in a press release.

Read More

Dr. Malone: Pfizer and Moderna Committed Fraud by Not Disclosing to Regulators COVID Jabs Contaminated with DNA Fragments

Pfizer and Moderna’s lack of transparency regarding DNA contamination in its COVID-19 shots “meets the criteria for evidence of fraud,” according to the doctor who invented the mRNA vaccine technology upon which the products are based.

“They [Pfizer and Moderna] absolutely did know about the existence of SV40 sequences,” vaccinologist Dr. Robert Malone told Republican lawmakers during a livestream House hearing Monday. Rep. Marjorie Taylor Greene (R-Ga.) led the event to examine injuries and deaths caused by COVID-19 vaccinations.

Read More

FDA Blasted for ‘Misleading’ mRNA COVID Vaccine Labels as ‘Sudden Death’ Research Mounts

Researchers around the world continue documenting potentially severe side effects from COVID-19 mRNA vaccines in certain demographics, but the Food and Drug Administration refuses to label them or even tell recipients the shots can’t stop transmission of an increasingly immune-evasive virus.

Autopsies and reviews of medical records revealed a much higher incidence of Pfizer and Moderna vaccine-associated heart deaths than officially categorized in South Korean, Japanese and Qatari government registries, particularly in younger people at lower risk from COVID. That echoes a German autopsy study of healthy people who died within 20 days of jabs.

Read More

Moderna Under Fire as CEO Earned Nearly $400 Million in Stock Options and a 50 Percent Raise Last Year

Moderna is under fire after financial records showed the biotech company’s CEO Stephane Bancel earned around $393 million in 2022 from stock options he exercised as he received a 50% raise.

Bancel, whose firm is known for producing the COVID-19 vaccine, received $1.5 million in 2022, an increase of 50% from 2021, and Moderna increased his target cash bonus, a March securities and exchange commission filing shows.

Read More

Biden Administration Attempting to Bail Out Moderna

The pharmaceutical company Moderna, which has already received over $10 billion in taxpayer funds for the development of its COVID-19 vaccine, could receive even more public money at the request of the Biden Administration.

According to the Washington Free Beacon, lawyers with the Department of Justice (DOJ) offered in court filings last month to “relieve” Moderna of any liabilities it may face as the result of a lawsuit claiming that the company has not paid licensing fees for the technology it utilized to develop its vaccine for the Chinese coronavirus.

Read More

Wall Street Journal Rips Vaccine Makers: ‘Designed Studies to Get the Results They Wanted’

Wall Street Journal (WSJ) editorial board member Allysia Finley took to task both the federal government and the pharmaceutical giants profiting from the sale of their COVID mRNA booster shots for a “deceptive advertising” push for Americans to continue taking boosters without proof of their safety or effectiveness. The U.S. Department of Health and Human Services (HHS) and its health and regulatory agencies are engaged in a “deceptive advertising” campaign, wrote Finley Sunday, suggesting the pressure tactics “shouldn’t come as a surprise,” since the federal government “took the unprecedented step of ordering vaccine makers to produce them and recommending them without data supporting their safety or efficacy.”

Read More

Pfizer and Moderna Conducting Studies to Assess Long-Term Impacts of Myocarditis

Nearly two years after their mRNA “vaccines” were released to the public, both Pfizer and Moderna are finally conducting clinical trials to track long-term adverse health effects following a diagnosis of vaccine-associated myocarditis and pericarditis in teens and young adults under the age of 21. Myocarditis  can cause permanent damage to heart muscle and even death.

Read More

Moderna Suing Pfizer for COVID-19 Vaccine Patent Infringement

Moderna is filing patent infringement lawsuits against Pfizer and BioNTech in U.S. district court and German regional court Friday in connection with the two companies’ COVID-19 vaccine, Moderna announced.

Moderna alleges Pfizer and BioNTech’s Comirnaty vaccine breaches its mRNA technology patents submitted between 2010 and 2016. It claims they developed their vaccine by copying the technology Moderna used to make its mRNA COVID-19 vaccine, Spikevax.

Read More

Ivy League Study: Boosters, COVID-19 ‘Rebounds’ Fuel Skepticism of Federal Narratives

As the nation’s most powerful and twice-boosted infectious disease doctor battles a COVID-19 “rebound” two weeks after testing positive, new research from the public health schools at Harvard and Yale suggests the boosted fared worse against the first Omicron subvariant than the non-boosted.

The FDA is so alarmed by the “waning effectiveness” of boosters, whose formulation is still based on the ancestral Wuhan strain, that it asked manufacturers Thursday to add a “spike protein component” from the fourth and fifth Omicron subvariants to this fall’s boosters.

Read More

FDA Quickly Authorizes COVID Shots for Infants and Young Children

The Food and Drug Administration (FDA) quickly authorized the Moderna and Pfizer-BioNTech COVID vaccine shots for infants and young children Friday, paving the way for the Centers for Disease Control and Prevention (CDC) advisory committee to vote on authorization over the weekend to allow the youngest children to get the shots as early as next week.

Per the press announcement by the FDA, the Emergency Use Authorization (EUA) for the Moderna COVID vaccine for older children and adults has been “amended” to “include use of the vaccine in individuals 6 months through 17 years of age,” while the EUA for the Pfizer COVID shot will now include use of the vaccine for babies as young as “6 months through 4 years of age.”

Read More

NIH Study: Vaccinated People Develop Fewer Antibodies Than Unvaccinated After COVID Infection

Unvaccinated people develop much broader antibody immunity after being infected with COVID than people who have received the mRNA shots do, according to an NIH study. And the gap was large whether subjects had mild, moderate, or severe COVID infections.

The results of the study, which were highlighted by Alex Berenson on his Unreported Truths Substack, Daniel Horowitz at the Blaze, and Igor Chudov on his Substack newsletter, completely destroy the regime narrative that the shots provide stronger immunity than a natural infection, and may help explain why so many vaccinated Americans are now suffering from multiple COVID infections.

Read More

Moderna Recalls More than 750,000 COVID-19 Vaccine Doses After ‘Foreign Body’ Found in Lot

The pharmaceutical company Moderna on Friday recalled 764,900 doses of its Spikevax COVID-19 vaccine after a “foreign body” was found in a vial.

The contaminated lot was manufactured at a contract manufacturing site, ROVI, in Spain, and was distributed in mid-January 2022 in Norway, Poland, Portugal, Sweden and Spain, according to a company press release.

Read More

Vaccine Manufacturer Moderna to Establish Presence in Georgia, Create 150 Jobs

healthcare worker with a mask and hairnet on

Moderna, the developer of one of the key COVID-19 vaccines, will open a new Enterprise Solutions Hub in Atlanta, according to a release from Governor Brian Kemp’s office.

The biotechnology company will create at least 150 new jobs over the next two years, as operations begin later this year.

Read More

CDC Shortens Isolation Window for Positive COVID-19 Result to Five Days

The Centers for Disease Control and Prevention has updated the amount of time it recommends people isolate themselves after testing positive for COVID-19, shortening it from 10 days to five.

“Given what we currently know about COVID-19 and the Omicron variant, CDC is shortening the recommended time for isolation from 10 days for people with COVID-19 to 5 days, if asymptomatic, followed by 5 days of wearing a mask when around others,” the CDC said in a statement Monday.

The CDC changed the guidance because officials believe the data indicates the majority of COVID-19 transmission takes place early in the course of the illness, “generally in the 1-2 days prior to onset of symptoms and the 2-3 days after,” the statement said.

Read More

FDA Approves Moderna and Pfizer Boosters for Adults

The Food and Drug Administration (FDA) approved Moderna and Pfizer’s COVID-19 vaccines for booster shot use for adults in the U.S., the agency announced Friday,

The announcement was made just two months after the FDA first rejected the White House’s plan to administer booster shots to all adults the week of Sept. 20. FDA Acting Commissioner Janet Woodcock approved the booster without holding the usual public meeting to review the data, and the Centers for Disease Control and Prevention (CDC) will meet Friday afternoon to discuss the authorization, according to the FDA press release.

“Throughout the course of the COVID-19 pandemic, the FDA has worked to make timely public health decisions as the pandemic evolves. COVID-19 vaccines have proven to be the best and highly effective defense against COVID-19,” Woodcock said in the press release.

Read More

Commentary: Vaccination Rates Not Linked to Lower COVID Rates, Epidemiology Paper Finds

On Friday, the San Francisco Chronicle published an article noting that California has some of the lowest COVID-19 case rates in the US, even though the Golden State’s vaccination rate lags many states that are currently struggling with the delta variant.

“One clear example is the New England states of Vermont and Maine,” the Chronicle reported. “Relatively shielded from the worst of the nation’s previous surges, they have struggled against the delta variant, which has sent their case rates soaring.”

Read More

Analysis: COVID-19 Is Not a ‘Pandemic of the Unvaccinated’

On Friday, September 17, the CDC published a study that refutes the common claim that COVID-19 is a “pandemic of the unvaccinated.” Coauthored by more than 50 MD’s and Ph.D.’s, the study contains data on the vaccine status of adults hospitalized with COVID-19 (C-19) at 21 U.S. hospitals across 18 states during March to August of 2021.

Contrary to assertions from the Associated Press and Anthony Fauci that fully vaccinated people comprise only 1% of those being hospitalized or killed by C-19, the study found that 13% of patients hospitalized with C-19 had been fully vaccinated. Moreover, that 13% figure is just the tip of the iceberg because the authors excluded from their study a large group of hospitalized C-19 patients, the bulk of whom were likely vaccinated.

Read More

Feds: Vaccinated Americans Will Need Booster Shots

The Biden administration announced Wednesday that federal health experts now recommend vaccinated Americans receive a COVID booster shot.

The boosters will be widely distributed to the public after research indicated that the vaccine’s effectiveness declines over time.

Read More

Biden Administration Allegedly Planning to Distribute Johnson and Johnson Vaccine to Illegal Aliens

Joe Biden is planning an effort to distribute doses of the Johnson & Johnson vaccine to illegal aliens pouring into the United States across the southern border, as reported by Breitbart.

The report first came from the Washington Post, after several officials with the Department of Homeland Security (DHS) spoke under condition of anonymity. According to the officials, federal authorities will soon begin administering the single-shot vaccine to illegals currently held in U.S. custody along the southern border with Mexico. DHS plans to get illegals vaccinated as soon as possible upon their entry into the country, to be done even before they are fully processed.

Read More

Not One State Reported a Sizable Increase in Coronavirus Cases Last Week

Sick person talking to CDC employee

For the first time in months, not one state reported a dramatic weekly increase in coronavirus cases.

While average daily cases fell by less than 10% in 11 states, 37 states saw cases fall by over 10% and just two states had cases marginally increase, according to data from Johns Hopkins University. The United States also averaged fewer than 40,000 daily cases last week, a 21% drop from the week prior and the lowest total since September.

Death and hospitalization rates have also plummeted nationwide. The U.S. has averaged 600 deaths per day, the lowest point in approximately 10 months. If the number continues to fall the nation could soon hit its lowest point of the entire pandemic, according to the Associated Press.

Read More

Vaccines Protect Against Multiple Variants, Additional Studies Suggest

Doctor with mask on holding COVID-19 Vaccine

The Pfizer and Moderna coronavirus vaccines are highly effective against and prevent illness from common variants of the virus, according to recently released studies.

The vaccine made by Pfizer is effective against the coronavirus variants that originated from the U.K. and South Africa, according to multiple studies released Wednesday that examined real-world vaccinations, The New York Times reported. Moderna reported that an early-stage trial suggested its vaccine is effective against the South African variant and a third variant originating from Brazil when given as a single-dose booster shot.

“At this point in time, we can confidently say that we can use this vaccine, even in the presence of circulating variants of concern,” London School of Hygiene and Tropical Medicine infectious disease researcher Annelies Wilder-Smith told the NYT.

Read More

Pfizer, Moderna Vaccines May Offer Less Protection Against South African Coronavirus Variant

Recent studies indicate that the Pfizer and Moderna coronavirus vaccines may have reduced protection against the South African coronavirus strain, according to reports in the New England Journal of Medicine, raising concerns that they could be less effective against future mutations.

Though both vaccines appeared to generate enough antibodies to neutralize the mutant strain, they both produced fewer antibodies when compared to the original virus. But experts warned that it was unclear just how much protection was needed to neutralize the variant, which scientists believe is more contagious than the original strain.

Read More

Coronavirus Vaccines Can Guard Against New, More Contagious UK Strain, Experts Say

The two coronavirus vaccines that have been approved for emergency use authorization in the U.S. will be able to combat a new, more contagious strain of the virus in the U.K., experts said Monday.

Vaccines made by pharmaceutical companies Pfizer and Moderna will be effective against the new strain, which is “very similar” to previous strains at the genetic level, University of Washington’s Institute for Health Metrics and Evaluation affiliate assistant professor Vin Gupta told CNBC. The Food and Drug Administration has approved both vaccines for emergency use authorization after large-scale human trials showed efficacy of more than 90%.

Read More

Tennessee Nurse Who Fainted After Receiving COVID-19 Vaccine Says It Was Due to Underlying Condition

The nurse who appeared to faint after receiving a COVID-19 vaccine in a viral video has recovered, according to a statement issued by her employer. Tiffany Dover, a nurse at CHI Memorial Hospital, reportedly came close to passing out due to a medical condition unrelated to the vaccination.

The hospital also cited information from the Centers for Disease Control (CDC) website, which stated that fainting sometimes occurs after all types of vaccinations.

Read More

FDA Grants Moderna’s Coronavirus Vaccine Emergency Authorization

The FDA approved Moderna’s coronavirus vaccine for emergency use Friday, making the United States the first country to have approved two safe and effective vaccines against COVID-19.

Its approval follows a key FDA panel’s overwhelming vote Thursday to endorse the vaccine’s safety and efficacy. The Moderna vaccine’s approval means that its distribution could begin within hours, providing hospitals and long-term care facilities across the country thousands of much-needed doses.

Read More

FDA Review Reaffirms Moderna Coronavirus Vaccine’s Safety, Efficacy

The FDA released data Tuesday reaffirming that Moderna’s coronavirus vaccine is safe and effective in preventing severe cases in adults.

The release is a sign that the vaccine is likely to be granted emergency use from the FDA in the coming days, public health officials said, a critical step in ensuring that millions of Americans can be vaccinated as soon as possible. The FDA released similar data regarding Pfizer’s vaccine just days before it was given emergency approval as well.

Read More

Vaccines Arrive in Georgia, Healthcare Personnel First to be Vaccinated

A total of 5,850 doses of vaccines arrived in Georgia Monday, as part of a “two-dose series.”

According to the Georgia Department of Public Health (DPH), “initial COVID-19 vaccine supply is limited, DPH is following the recommendations of the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP) and prioritizing healthcare personnel and residents of long-term care facilities for vaccination. Vaccine will be given through closed points of dispensing or PODs. These sites include public health clinics, hospitals, long-term care facilities, pharmacies, etc., and are only accessible to individuals in defined priority groups.”

Read More

Moderna Asks FDA for Emergency Approval of COVID-19 Vaccine, Second Company to Pass Milestone

Pharmaceutical company Moderna announced Monday that it will submit its coronavirus vaccine to the federal government for emergency use authorization approval.

Moderna said it would ask the Food and Drug Administration (FDA) for approval after its large-scale human trial concluded and showed the company’s vaccine to have an overall efficacy of 94.1%, according to NBC News. The vaccine was found to be 100% effective in preventing severe cases of coronavirus, according to Moderna.

Read More

COVID-19 Vaccine Temperature Requirements Could Create Logistics Challenge

Many states in the U.S. are hinging their COVID-19 mitigation strategies on the availability of a widely available vaccine. An issue bound to arise is the extremely cold temperatures the most promising experimental vaccines need to be kept at and the logistics of delivering them across the country. 

Moderna’s COVID-19 vaccine is estimated to remain stable at standard refrigerator temperatures of 36° to 46°F for 30 days. Longer storage means a required temperature of mRNA-1273 needs -4°F for up to six months. 

Read More